Clinical characteristics of radiation-induced brainstem injury after radiotherapy in patients with head and neck tumors
10.3760/cma.j.cn112271-20210926-00393
- VernacularTitle:头颈部肿瘤患者放疗后放射性脑干损伤的临床特征分析
- Author:
Yuhua YANG
1
;
Honghong LI
;
Jialin HUANG
;
Jiatian XIE
;
Shaojian LI
;
Yamei TANG
Author Information
1. 中山大学孙逸仙纪念医院神经科，广州 510120
- Keywords:
Radiation-induced brain injury;
Clinical characteristics;
Clinical outcome
- From:
Chinese Journal of Radiological Medicine and Protection
2022;42(3):194-197
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To provide insight into the clinical characteristics, therapy and prognosis of patients with radiation-induced brainstem injury after radiotherapy.Methods:From August 2013 to September 2021, 13 patients with radiation-induced brainstem injury were included in this study at Sun Yat-sen Memorial Hospital, and the general information and strategy of radiotherapy were collected. A retrospective analysis was adopted to investigate the clinical and radiological characteristics, treatment and clinical outcomes.Results:There were 13 cases in total, including 4 females and 9 males. The onset age of enrolled patients ranged from 29 to 66 years with an average of (48.15±10.23) years. The median dose targeted at tumor area was 70 Gy with in 33 fractions. The median interval between radiotherapy and the diagnosis of radiation-induced brainstem injury was 24 months. The common clinical manifestations included dysphagia, bucking dysarthria, dizziness and problem with balance. The MRI radiological features were hypointense on T1WI, hyperintense on T2WI, and irregularly enhanced with contrast. The median follow-up was 45 months. Seven cases got improvements, while 3 had no obvious efficacy and 3 cases died. No significant differences in prognosis were observed between those received traditional glucocorticoid and those received bevacizumab treatment( P=0.079). Conclusions:The common symptoms of radiation-induced brainstem injury were symptoms of posterior cranial nerves injury and ataxia. Lesions mostly happened in pons and medulla, with hypointense on T1WI and hyperintense on T2WI. Half of the patients have improved after treatment. There was no significant difference in prognosis between glucocorticoid and bevacizumab treatment.
